Table 1.
Detailed information of treatment
| Disease category | University hospital | Community hospital | Medical practice | Ambulatory health care center | All institutions |
|---|---|---|---|---|---|
| Degenerative diseases | |||||
| Total institutions | n = 15 | n = 19 | n = 13 | n = 28 | n = 75 |
| Total patients | 4582 (13.5%) | 7692 (22.6%) | 6180 (18.1%) | 15,588 (45,8%) | 34,042 (100%) |
| Patients (mean ± SD) | 11 ± 536 | 250 ± 495 | 350 ± 417 | 245 ± 690 | 258 ± 572 |
| Range | 11-2102 | 5-692 | 37-1500 | 0-2818 | 0-2818 |
| Hyperproliferative diseases | |||||
| Total institutions | n = 15 | n = 17 | n = 12 | n = 24 | n = 68 |
| Total patients | 283 (22.5%) | 232 (18.4%) | 226 (18%) | 518 (41.1%) | 1259 (100%) |
| Patients (mean ± SD) | 5 ± 49 | 8 ± 14 | 17 ± 15 | 9 ± 42 | 8 ± 35 |
| Range | 0-194 | 0-46 | 1-51 | 0-206 | 0-206 |
| Functional diseases | |||||
| Total institutions | n = 16 | n = 20 | n = 14 | n = 22 | n = 72 |
| Total patients | 403 (16.9%) | 908 (38.1%) | 439 (18.4%) | 634 (26.6%) | 2384 (100%) |
| Patients (mean ± SD) | 21 ± 21 | 25 ± 68 | 15 ± 61 | 21 ± 23 | 20 ± 47 |
| Range | 3-90 | 2-314 | 2-241 | 0-75 | 0-314 |
| Stereotactic indications | |||||
| Total institutions | n = 15 | n = 12 | n = 9 | n = 21 | n = 57 |
| Total patients | 654 (77.9%) | 50 (6%) | 21 (2.5%) | 114 (13.6%) | 839 (100%) |
| Patients (mean ± SD) | 30 ± 61 | 2 ± 6 | 0 ± 6 | 0 ± 12 | 2 ± 36 |
| Range | 3-249 | 0-17 | 0-17 | 0-37 | 0-249 |
| Rare indications | |||||
| Total institutions | n = 11 | n = 10 | n = 12 | n = 20 | n = 53 |
| Total patients | 20 (40.8%) | 4 (8.2%) | 15 (30.6%) | 10 (20.4%) | 49 (100%) |
| Patients (mean ± SD) | 1 ± 3 | 0 ± 1 | 0 ± 3 | 0 ± 1 | 0 ± 2 |
| Range | 0-8 | 0-1 | 0-8 | 0-5 | 0-8 |
SD, standard deviation.